5316422026-10-055316422026-10-052026-10-055316422026-10-05in-capmkt:FinancialYear1Member5316422026-10-05in-capmkt:FinancialYear2Member5316422026-10-05in-capmkt:FinancialYear3Member5316422026-10-052026-10-05in-capmkt:FinancialYear1Member5316422026-10-052026-10-05in-capmkt:FinancialYear2Member5316422026-10-052026-10-05in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure531642MARICO LIMITEDMARICONOTLISTEDINE196A01026NewAcquisition (including agreement to acquire)false2026-10-0520:01:002026-10-05Marico LimitedListed Entity (self)Satiya Nutraceuticals Private Limited (“Satiya Nutraceuticals”), and its wholly owned subsidiary, Juizo Advisory Private Limited (“Juizo”).8643100000259000000872000000true2026-08-042026-09-25falsefalsetrueHealth, Wellness & Personal careSatiya Nutraceuticals is a subsidiary of the Company, with Marico currently holding 60% stake on a fully diluted basis. The strategic investment in Satiya Nutraceuticals has expanded Marico’s total addressable market in the value-added foods and nutrition segments as well as presence in rapidly growing personal care and wellness categories. The current transaction is towards acquisition of the 38.18% stake held by Founders and certain other shareholders in Satiya Nutraceuticals, pursuant to the rights under the definitive agreement(s).Notrue05-10-2026Cash10120300000Consideration of ₹ 1,012.03 Crores towards current tranche of acquisition of 24.09% stake in Satiya Nutraceuticals on a fully diluted basis.101203000000.60.84090.2409Satiya Nutraceuticals Private Limited, a company incorporated under the Companies Act 2013 on February 13, 2020 is headquartered at Mumbai, Maharashtra and owns ‘The Plant Fix – Plix’, a leading plant- based nutrition & personal care brand with a strong presence in rapidly growing health and wellness segments.2020-02-132025-202686431000002024-202543284000002023-20241553200000IndiaConsideration of ₹ 1,012.03 Crores towards current tranche of acquisition of 24.09% stake in Satiya Nutraceuticals on a fully diluted basis. Accordingly, the aggregate consideration for acquisition of 84.09% stake on a fully diluted basis in Satiya Nutraceuticals stands at ₹ 1,392.07 Crores. The remaining stake of 14.09% held by Founder and certain other shareholders will be acquired for an aggregate consideration to be determined at such time which shall comprise a base consideration of up to ₹ 592 Crores and additional consideration subject to milestones, terms and conditions under the definitive agreement(s). As part of the current tranche, the Company has acquired 24.09% stake, thereby increasing its aggregate stake from 60% to 84.09% on a fully diluted basis. The remaining 14.09% stake held by Founder and certain other shareholders will be acquired in July 2027, subject to terms and conditions of the definitive agreements. The details of Turnover, PAT, Net Worth provided above is on a consolidated basis.